Irene Chang Britt - 06 May 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Irene Chang Britt
Issuer symbol
IDXX
Transactions as of
06 May 2024
Net transactions value
$0
Form type
4
Filing time
08 May 2024, 19:00:35 UTC
Previous filing
06 Sep 2023
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +208 $0.000000 208 06 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +609 $0.000000 609 06 May 2024 Common Stock 609 $476.87 Direct F1
transaction IDXX Deferred Stock Unit Award $0 +262 $0.000000 262 06 May 2024 Common Stock 262 Direct F2
transaction IDXX Restricted Stock Unit Options Exercise $0 -208 -100% $0.000000* 0 06 May 2024 Common Stock 208 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier.
F2 Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.
F3 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event was earlier.